Related Experiment Video
Updated: Aug 18, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
A new CARD15 mutation in Blau syndrome
Marjan M van Duist1, Mario Albrecht, Marta Podswiadek
1Department of Clinical and Biological Sciences, Division of Medical Genetics, University of Torino, Orbassano, Italy.
Insights
Researchers identified a new mutation (E383K) in the CARD15/NOD2 gene causing Blau syndrome, a rare inflammatory disease. This finding advances understanding of innate immunity pathways and genetic susceptibility to inflammatory disorders.
Area of Science:
- Genetics
- Immunology
- Molecular Biology
Background:
- The CARD15/NOD2 gene encodes a cellular receptor crucial for innate immunity via the NF-kappaB pathway.
- CARD15/NOD2 is a key susceptibility gene for Crohn's disease (CD) and the causative gene for Blau syndrome (BS).
- CD-associated variants decrease NF-kappaB activation, while BS mutations increase it.
Purpose of the Study:
- To identify the genetic basis of Blau syndrome in an Italian family.
- To characterize the functional impact of a novel CARD15/NOD2 mutation on NF-kappaB signaling.
- To explore the role of the NACHT domain in autoinflammatory diseases.
Main Methods:
- Genetic analysis of an Italian family with Blau syndrome.
- Mutation detection and pathogenicity assessment (cosegregation, control analysis).
- Analysis of protein domain conservation and structural role.
Main Results:
- A novel mutation, E383K, was identified in the CARD15/NOD2 gene of the affected family.
- The E383K mutation cosegregated with Blau syndrome in the family and was absent in controls.
- The mutation affects a conserved glutamate residue near the Walker B motif in the NACHT domain, crucial for nucleotide binding.
Conclusions:
- The E383K mutation in CARD15/NOD2 is pathogenic and causes Blau syndrome.
- This finding highlights the critical role of the NACHT domain in regulating NF-kappaB activation and innate immunity.
- Mutations in NACHT domain-containing proteins can lead to autoinflammatory phenotypes.
Abstract:
The caspase recruitment domain gene CARD15/NOD2, encoding a cellular receptor involved in an NF-kappaB-mediated pathway of innate immunity, was first identified as a major susceptibility gene for Crohn's disease (CD), and more recently, as responsible for Blau syndrome (BS), a rare autosomal-dominant trait characterized by arthritis, uveitis, skin rash and granulomatous inflammation. While CARD15 variants associated with CD are located within or near the C-terminal leucine-rich repeat domain and cause decreased NF-kappaB activation, BS mutations affect the central nucleotide-binding NACHT domain and result in increased NF-kappaB activation. In an Italian family with BS, we detected a novel mutation E383K, whose pathogenicity is strongly supported by cosegregation with the disease in the family and absence in controls, and by the evolutionary conservation and structural role of the affected glutamate close to the Walker B motif of the nucleotide-binding site in the NACHT domain. Interestingly, substitutions at corresponding positions in another NACHT family member cause similar autoinflammatory phenotypes.
Related Concept Videos
Genetic Lingo
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pleiotropy
Mutations
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Sex-linked Disorders

